Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan W Partin

Showing results (291-300 of 349) with videos related to

Pageof 35
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 4, 2021
Adjuvant Versus Early Salvage Radiation Therapy for Men at High Risk for Recurrence Following Radical Prostatectomy for Prostate Cancer and the Risk of DeathDerya Tilki, Ming-Hui Chen, Jing Wu, et al.
Urology|December 11, 2003
Volume indexes of total, free, and complexed prostate-specific antigen enhance prediction of extraprostatic disease extension in men with nonpalpable prostate cancerYoshio Naya, Herbert A Fritsche, Carol D Cheli, et al.
The Journal of Urology|April 17, 2002
Comparative analysis of complexed prostate specific antigen, free prostate specific antigen and their ratio in detecting prostate cancerKoji Okihara, Carol D Cheli, Alan W Partin, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 4, 2012
Variation in IL10 and other genes involved in the immune response and in oxidation and prostate cancer recurrencePaul J Dluzniewski, Ming-Hsi Wang, Siqun Lilly Zheng, et al.
Urology|October 18, 2002
Complexed prostate-specific antigen for early detection of prostate cancer in men with serum prostate-specific antigen levels of 2 to 4 nanograms per milliliterWolfgang Horninger, Carol D Cheli, Richard J Babaian, et al.
The Journal of Molecular Diagnostics : JMD|December 6, 2016
Analytical Validation of Androgen Receptor Splice Variant 7 Detection in a Clinical Laboratory Improvement Amendments (CLIA) Laboratory SettingParvez M Lokhandwala, Stacy L Riel, Lisa Haley, et al.
BJU International|July 2, 2024
Association of Genomic Prostate Score at positive margin with recurrence after radical prostatectomySanaz Nourmohammadi Abadchi, Daniela C Salles, Cynthia Flannery, et al.
International Journal of Surgical Pathology|April 9, 2013
Comparison of biochemical recurrence-free survival between periprostatic and pelvic lymph node metastases of prostate cancerNilda González-Roibón, Jeong S Han, Stephen Lee, et al.
Urology|October 18, 2002
Can volume measurement of the prostate enhance the performance of complexed prostate-specific antigen?Yoshio Naya, Thomas A Stamey, Carol D Cheli, et al.
JAMA|November 16, 2006
Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trialLeonard S Marks, Norman A Mazer, Elahe Mostaghel, et al.
Pageof 35

Showing results (291-300 of 349) with videos related to

Sort By:
Pageof 35
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 4, 2021
Adjuvant Versus Early Salvage Radiation Therapy for Men at High Risk for Recurrence Following Radical Prostatectomy for Prostate Cancer and the Risk of DeathDerya Tilki, Ming-Hui Chen, Jing Wu, et al.
Urology|December 11, 2003
Volume indexes of total, free, and complexed prostate-specific antigen enhance prediction of extraprostatic disease extension in men with nonpalpable prostate cancerYoshio Naya, Herbert A Fritsche, Carol D Cheli, et al.
The Journal of Urology|April 17, 2002
Comparative analysis of complexed prostate specific antigen, free prostate specific antigen and their ratio in detecting prostate cancerKoji Okihara, Carol D Cheli, Alan W Partin, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 4, 2012
Variation in IL10 and other genes involved in the immune response and in oxidation and prostate cancer recurrencePaul J Dluzniewski, Ming-Hsi Wang, Siqun Lilly Zheng, et al.
Urology|October 18, 2002
Complexed prostate-specific antigen for early detection of prostate cancer in men with serum prostate-specific antigen levels of 2 to 4 nanograms per milliliterWolfgang Horninger, Carol D Cheli, Richard J Babaian, et al.
The Journal of Molecular Diagnostics : JMD|December 6, 2016
Analytical Validation of Androgen Receptor Splice Variant 7 Detection in a Clinical Laboratory Improvement Amendments (CLIA) Laboratory SettingParvez M Lokhandwala, Stacy L Riel, Lisa Haley, et al.
BJU International|July 2, 2024
Association of Genomic Prostate Score at positive margin with recurrence after radical prostatectomySanaz Nourmohammadi Abadchi, Daniela C Salles, Cynthia Flannery, et al.
International Journal of Surgical Pathology|April 9, 2013
Comparison of biochemical recurrence-free survival between periprostatic and pelvic lymph node metastases of prostate cancerNilda González-Roibón, Jeong S Han, Stephen Lee, et al.
Urology|October 18, 2002
Can volume measurement of the prostate enhance the performance of complexed prostate-specific antigen?Yoshio Naya, Thomas A Stamey, Carol D Cheli, et al.
JAMA|November 16, 2006
Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trialLeonard S Marks, Norman A Mazer, Elahe Mostaghel, et al.
Pageof 35